BNP Paribas Financial Markets Grows Holdings in Simulations Plus, Inc. (NASDAQ:SLP)

BNP Paribas Financial Markets boosted its position in Simulations Plus, Inc. (NASDAQ:SLP) by 402.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,944 shares of the technology company’s stock after buying an additional 32,002 shares during the quarter. BNP Paribas Financial Markets owned 0.20% of Simulations Plus worth $1,279,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Quantbot Technologies LP acquired a new position in shares of Simulations Plus in the third quarter worth about $59,000. Pitcairn Co. increased its holdings in Simulations Plus by 9.1% during the 3rd quarter. Pitcairn Co. now owns 6,599 shares of the technology company’s stock worth $211,000 after purchasing an additional 549 shares during the last quarter. First Horizon Advisors Inc. raised its position in shares of Simulations Plus by 82.6% in the 3rd quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company’s stock valued at $26,000 after purchasing an additional 370 shares in the last quarter. Mutual of America Capital Management LLC boosted its stake in shares of Simulations Plus by 18.7% during the 3rd quarter. Mutual of America Capital Management LLC now owns 85,275 shares of the technology company’s stock valued at $2,731,000 after buying an additional 13,418 shares during the last quarter. Finally, Royce & Associates LP boosted its stake in shares of Simulations Plus by 28.8% during the 3rd quarter. Royce & Associates LP now owns 237,416 shares of the technology company’s stock valued at $7,602,000 after buying an additional 53,092 shares during the last quarter. 78.08% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on SLP shares. William Blair reaffirmed an “outperform” rating on shares of Simulations Plus in a report on Wednesday, November 6th. Stephens started coverage on shares of Simulations Plus in a research note on Friday, November 15th. They issued an “overweight” rating and a $39.00 target price on the stock. BTIG Research decreased their price target on Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research note on Thursday, October 24th. Finally, StockNews.com cut Simulations Plus from a “hold” rating to a “sell” rating in a research note on Monday, November 4th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $51.40.

Simulations Plus Stock Up 0.9 %

Shares of SLP stock opened at $30.40 on Tuesday. The company has a market cap of $610.13 million, a P/E ratio of 62.04 and a beta of 0.76. The business has a 50 day moving average of $30.76 and a two-hundred day moving average of $36.76. Simulations Plus, Inc. has a 52 week low of $27.07 and a 52 week high of $51.22.

Simulations Plus (NASDAQ:SLP) last released its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The business had revenue of $18.70 million during the quarter, compared to analyst estimates of $19.73 million. During the same quarter in the previous year, the firm posted $0.18 EPS. The business’s revenue for the quarter was up 19.9% compared to the same quarter last year. Analysts expect that Simulations Plus, Inc. will post 1.1 EPS for the current fiscal year.

Insider Transactions at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $31.76, for a total transaction of $635,200.00. Following the sale, the director now owns 3,442,584 shares of the company’s stock, valued at $109,336,467.84. The trade was a 0.58 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last quarter, insiders sold 60,750 shares of company stock worth $1,837,255. Insiders own 20.90% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.